Cargando…
Monogenic disease analysis establishes that fetal insulin accounts for half of human fetal growth
Autores principales: | Hughes, Alice E., De Franco, Elisa, Freathy, Rachel M., Flanagan, Sarah E., Hattersley, Andrew T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014100/ https://www.ncbi.nlm.nih.gov/pubmed/36808723 http://dx.doi.org/10.1172/JCI165402 |
Ejemplares similares
-
Two decades since the fetal insulin hypothesis: what have we learned from genetics?
por: Hughes, Alice E., et al.
Publicado: (2021) -
Noninvasive Fetal Genotyping by Droplet Digital PCR to Identify Maternally Inherited Monogenic Diabetes Variants
por: Caswell, Richard C., et al.
Publicado: (2020) -
Fetal growth prediction: Establishing fetal growth prediction curves in the second trimester
por: Wang, Yan, et al.
Publicado: (2021) -
Fetal Bradycardia Caused by Monogenic Disorders—A Review of the Literature
por: Westphal, Dominik S., et al.
Publicado: (2022) -
The Effects of Fetal Gender on Maternal and Fetal Insulin Resistance
por: Walsh, Jennifer M., et al.
Publicado: (2015)